Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$555M |
| 2 |
Citigroup
C
|
+$407M |
| 3 |
Medtronic
MDT
|
+$401M |
| 4 |
Chipotle Mexican Grill
CMG
|
+$392M |
| 5 |
Gilead Sciences
GILD
|
+$362M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.43B |
| 2 |
Amazon
AMZN
|
+$1.32B |
| 3 |
Apple
AAPL
|
+$1.1B |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$995M |
| 5 |
Bank of America
BAC
|
+$726M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 83.47% |
| 2 | Technology | 3.02% |
| 3 | Healthcare | 2.92% |
| 4 | Consumer Discretionary | 2.17% |
| 5 | Financials | 2.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
PWCM
11151
PowerCompute Inc
PWCM
$1.81M
| $92.9K | ﹤0.01% |
1,397
+280
| +25% | +$23K |
2024 Q2
1 quarter
|
|
11152
PUT
Pyxis Oncology
PYXS
$168M
| $92.9K | ﹤0.01% |
25,300
+20,300
| +406% | +$71K |
2023 Q4
3 quarters
|
|
11153
Gladstone Investment Corp
GAIN
$609M
| $92.7K | ﹤0.01% |
6,416
-14,084
| -69% | -$190K |
2022 Q2
9 quarters
|
|
11154
PUT
Takeda Pharmaceutical
TAK
$58.7B
| $92.4K | ﹤0.01% |
6,500
+700
| +12% | +$9.93K |
2019 Q1
22 quarters
|
|
11155
CALL
iShares Core US REIT ETF
USRT
$4.22B
| $92.4K | ﹤0.01% |
1,500
| – | – |
2023 Q1
6 quarters
|
|
|
MPX
11156
CALL
DELISTED
Marine Products Corp
MPX
| $92.1K | ﹤0.01% |
9,500
-12,200
| -56% | -$117K |
2021 Q1
14 quarters
|
|
11157
CALL
Vitamin Cottage Natural Grocers
NGVC
$692M
| $92K | ﹤0.01% |
3,100
-2,400
| -44% | -$60.9K |
2022 Q4
7 quarters
|
|
11158
CALL
CTS Corp
CTS
$1.66B
| $91.9K | ﹤0.01% |
1,900
-900
| -32% | -$43.7K |
2023 Q4
3 quarters
|
|
11159
CALL
State Street SPDR Bloomberg Convertible Securities ETF
CWB
$5.54B
| $91.9K | ﹤0.01% |
1,200
-3,600
| -75% | -$264K |
2021 Q1
14 quarters
|
|
|
VIOT
11160
Viomi Technology
VIOT
$101M
| $91.8K | ﹤0.01% |
59,243
-4,239
| -7% | -$5.14K |
2024 Q2
1 quarter
|
|
11161
BGSF Inc
BGSF
$50.2M
| $91.7K | ﹤0.01% |
10,891
-6,803
| -38% | -$54.9K |
2024 Q2
1 quarter
|
|
|
SVC
11162
PUT
Service Properties Trust
SVC
$826M
| $91.7K | ﹤0.01% |
4,020
+2,660
| +196% | +$66.2K |
2013 Q2
45 quarters
|
|
|
NFBK
11163
PUT
DELISTED
Northfield Bancorp
NFBK
| $91.6K | ﹤0.01% |
+7,900
| New | +$90.6K |
2024 Q3
0 quarters
|
|
|
DSL
11164
DoubleLine Income Solutions Fund
DSL
$1.12B
| $91.6K | ﹤0.01% |
7,055
-2,631
| -27% | -$33.6K |
2023 Q1
6 quarters
|
|
|
SMCX
11165
PUT
Defiance Daily Target 2X Long SMCI ETF
SMCX
$225M
| $91.6K | ﹤0.01% |
+295
| New | +$119K |
2024 Q3
0 quarters
|
|
11166
CALL
Schwab US Mid-Cap ETF
SCHM
$14.5B
| $91.4K | ﹤0.01% |
3,300
+2,700
| +450% | +$71.8K |
2021 Q3
12 quarters
|
|
|
11167
PUT
Schwab US Mid-Cap ETF
SCHM
$14.5B
| $91.4K | ﹤0.01% |
3,300
-5,700
| -63% | -$152K |
2023 Q1
6 quarters
|
|
|
IHTA
11168
DELISTED
Invesco High Income 2024 Target Term Fund
IHTA
| $91.2K | ﹤0.01% |
11,995
+700
| +6% | +$5.2K |
2024 Q2
1 quarter
|
|
11169
PUT
Butterfly Network
BFLY
$2.2B
| $91.2K | ﹤0.01% |
51,500
+1,400
| +3% | +$1.75K |
2020 Q4
15 quarters
|
|
11170
CALL
Defiance R2000 Weekly Distribution ETF
IWMY
$85.1M
| $91.1K | ﹤0.01% |
+2,454
| New | +$96.7K |
2024 Q3
0 quarters
|
|
11171
PUT
COPT Defense Properties
CDP
$3.79B
| $91K | ﹤0.01% |
3,000
-5,200
| -63% | -$148K |
2022 Q4
7 quarters
|
|
11172
PUT
Northwest Bancshares
NWBI
$2.16B
| $91K | ﹤0.01% |
6,800
-500
| -7% | -$6.56K |
2022 Q4
7 quarters
|
|
|
CLSD
11173
DELISTED
Clearside Biomedical
CLSD
| $90.9K | ﹤0.01% |
4,774
-1,668
| -26% | -$28.5K |
2022 Q4
7 quarters
|
|
11174
CALL
Personalis
PSNL
$1.71B
| $90.9K | ﹤0.01% |
16,900
-10,600
| -39% | -$43.7K |
2023 Q4
3 quarters
|
|
11175
PUT
Inhibrx
INBX
$1.37B
| $90.8K | ﹤0.01% |
+5,800
| New | +$81.5K |
2024 Q3
0 quarters
|
|
Similar funds
Citadel Advisors's Q3 2024 Portfolio in Review
As of Q3 2024, Citadel Advisors held 15,731 positions worth $518B, up 4.9% from $494B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Citadel Advisors's Q3 2024 filing shows 1,612 new, 6,434 increased, 5,866 reduced and 1,610 closed positions. Its largest new stake was iShares 7-10 Year Treasury Bond ETF: 2,002,737 shares worth $197M. The largest sale was Invesco QQQ Trust, an estimated $1.43B.
By sector, the portfolio is most concentrated in Miscellaneous at 83% of assets, up from 82% a quarter earlier, followed by Technology and Healthcare.
- Citadel Advisors's largest Q3 2024 buy was iShares 7-10 Year Treasury Bond ETF: 2,002,737 shares worth $197M.
- Citadel Advisors added most to NVIDIA in Q3 2024, an estimated $555M increase.
- Citadel Advisors's biggest Q3 2024 reduction was Invesco QQQ Trust, cutting an estimated $1.43B.
- Citadel Advisors fully exited Domino's in Q3 2024, selling an estimated $186M.
- Citadel Advisors's ten largest holdings make up 30% of its $518B portfolio in Q3 2024.
- Citadel Advisors opened 1,612 new positions and closed 1,610 in Q3 2024.
- Citadel Advisors's portfolio value rose 4.9% quarter-over-quarter to $518B.
Based on Citadel Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.